Legend Biotech (LEGN)

• Market cap: $3.62B
• 1 day: -0.48%
• 5 days: 0.65%
• 1 month: -6.48%
• 3 months: -31.99%
• 6 months: 2.31%
• Year to date: -13.44%
• 1 year: -42.21%
• 5 years: -67.32%
• 10 years: -49.68%
• Sector: Healthcare
• Industry: Biotechnology

About: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 3,200